Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership65,012 shares
Latest Disclosed Value $ 675,475
Group One Trading, L.p. ownership in KUR / Kura Oncology, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 65,012 shares of Kura Oncology, Inc. (DE:KUR) valued at $566,255 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 76,627 shares of Kura Oncology, Inc.. This represents a change in shares of -15.16% during the quarter. The current value of the position is $491,491 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (KUR) in the form of stock options. The firm currently holds call options representing 51,100 of underlying shares valued at $530,929 USD and put options representing 16,300 of underlying shares valued at $169,357 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:KUR / Kura Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F KURA ONCOLOGY COM 50127T109 65,012 -11,615 -15.16 675 -0.44 0.0012
2025-11-12 2025-09-30 13F KURA ONCOLOGY COM 50127T109 76,627 76,627 678 0.0012
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 0 -2,125 -100.00 0 -100.00
2024-05-10 2024-03-31 13F KURA ONCOLOGY COM 50127T109 2,125 1,892 812.02 45 1,400.00 0.0002
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 233 233 3 0.0000
2023-11-09 2023-09-30 13F KURA ONCOLOGY COM 50127T109 0 -7,745 -100.00 0 -100.00
2023-08-09 2023-06-30 13F KURA ONCOLOGY COM 50127T109 7,745 7,745 82 0.0003
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM 50127T109 0 -6,296 -100.00 0 -100.00
2022-05-12 2022-03-31 13F KURA ONCOLOGY COM 50127T109 6,296 6,296 101 0.0001
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM 50127T109 0 -3,263 -100.00 0 -100.00
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM 50127T109 3,263 587 21.94 61 8.93 0.0001
2021-08-10 2021-06-30 13F KURA ONCOLOGY COM 50127T109 2,676 0 0.00 56 -26.32 0.0001
2021-05-12 2021-03-31 13F KURA ONCOLOGY COM 50127T109 2,676 -8,179 -75.35 76 -78.59 0.0001
2021-02-10 2020-12-31 13F KURA ONCOLOGY COM 50127T109 10,855 9,927 1,069.72 355 1,167.86 0.0006
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM 50127T109 928 -2,163 -69.98 28 -44.00 0.0001
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM 50127T109 3,091 1,296 72.20 50 177.78 0.0002
2020-05-13 2020-03-31 13F KURA ONCOLOGY COM 50127T109 1,795 -757 -29.66 18 -48.57 0.0001
2020-02-10 2019-12-31 13F KURA ONCOLOGY COM 50127T109 2,552 2,552 42.17 35 94.44 0.0002
2019-05-14 2019-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 0 -761 -100.00 0 -100.00
2019-02-05 2018-12-31 13F KURA ONCOLOGY COM 50127T109 761 4 0.53 11 -15.38 0.0001
2018-11-08 2018-09-30 13F KURA ONCOLOGY COM 50127T109 757 150 24.71 13 18.18 0.0001
2018-08-13 2018-06-30 13F KURA ONCOLOGY COM 50127T109 607 54 9.76 11 10.00 0.0001
2018-05-16 2018-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 553 553 10 0.0001
2018-05-10 2018-03-31 13F KURA ONCOLOGY COM 50127T109 553 10 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F KURA ONCOLOGY COM Call 51,100 84.48 531 116.33 n/a n/a n/a
2025-11-12 2025-09-30 13F KURA ONCOLOGY COM Call 27,700 24.77 245 91.41 n/a n/a n/a
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM Call 22,200 47.02 128 29.29 n/a n/a n/a
2025-05-14 2025-03-31 13F KURA ONCOLOGY COM Call 15,100 -44.28 100 -58.05 n/a n/a n/a
2025-05-14 2024-12-31 13F/A KURA ONCOLOGY COM Call 27,100 236 n/a n/a n/a
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM Call 27,100 236 n/a n/a n/a
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM Call 2,600 -73.20 54 -74.27 n/a n/a n/a
2024-05-10 2024-03-31 13F KURA ONCOLOGY COM Call 9,700 1,840.00 207 2,842.86 n/a n/a n/a
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM Call 500 -95.24 7 -92.63 n/a n/a n/a
2023-11-09 2023-09-30 13F KURA ONCOLOGY COM Call 10,500 0.00 96 -14.41 n/a n/a n/a
2023-08-09 2023-06-30 13F KURA ONCOLOGY COM Call 10,500 43.84 111 24.72 n/a n/a n/a
2023-05-12 2023-03-31 13F KURA ONCOLOGY COM Call 7,300 -83.41 89 -83.70 n/a n/a n/a
2023-02-09 2022-12-31 13F KURA ONCOLOGY COM Call 44,000 456.96 546 405.56 n/a n/a n/a
2022-11-09 2022-09-30 13F KURA ONCOLOGY COM Call 7,900 -63.26 108 -72.59 n/a n/a n/a
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM Call 21,500 -11.16 394 1.29 n/a n/a n/a
2022-05-12 2022-03-31 13F KURA ONCOLOGY COM Call 24,200 -46.70 389 -38.84 n/a n/a n/a
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM Call 45,400 -13.19 636 -35.10 n/a n/a n/a
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM Call 52,300 12,975.00 980 12,150.00 n/a n/a n/a
2021-08-10 2021-06-30 13F KURA ONCOLOGY COM Call 400 -80.95 8 -86.44 n/a n/a n/a
2021-05-12 2021-03-31 13F KURA ONCOLOGY COM Call 2,100 -84.33 59 -86.53 n/a n/a n/a
2021-02-10 2020-12-31 13F KURA ONCOLOGY COM Call 13,400 -59.64 438 -56.93 n/a n/a n/a
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM Call 33,200 1,006.67 1,017 1,975.51 n/a n/a n/a
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM Call 3,000 -90.96 49 -95.18 n/a n/a n/a
2019-02-05 2018-12-31 13F KURA ONCOLOGY COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F KURA ONCOLOGY COM Call 200 -66.67 4 -63.64 n/a n/a n/a
2018-08-13 2018-06-30 13F KURA ONCOLOGY COM Call 600 50.00 11 37.50 n/a n/a n/a
2018-05-16 2018-03-31 13F/A KURA ONCOLOGY COM Call 400 33.33 8 60.00 n/a n/a n/a
2018-05-10 2018-03-31 13F KURA ONCOLOGY COM Call 400 8 n/a n/a n/a
2018-02-09 2017-12-31 13F KURA ONCOLOGY COM Call 300 5 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F KURA ONCOLOGY COM Put 16,300 185.96 169 238.00 n/a n/a n/a
2025-11-12 2025-09-30 13F KURA ONCOLOGY COM Put 5,700 128.00 50 257.14 n/a n/a n/a
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM Put 2,500 108.33 14 100.00 n/a n/a n/a
2025-05-14 2025-03-31 13F KURA ONCOLOGY COM Put 1,200 20.00 8 -12.50 n/a n/a n/a
2025-05-14 2024-12-31 13F/A KURA ONCOLOGY COM Put 1,000 900.00 9 700.00 n/a n/a n/a
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM Put 1,000 9 n/a n/a n/a
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM Put 100 0.00 2 -50.00 n/a n/a n/a
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM Put 100 -99.44 2 -99.47 n/a n/a n/a
2024-05-10 2024-03-31 13F KURA ONCOLOGY COM Put 17,800 380 n/a n/a n/a
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F KURA ONCOLOGY COM Put 6,000 185.71 55 145.45 n/a n/a n/a
2023-08-09 2023-06-30 13F KURA ONCOLOGY COM Put 2,100 22 n/a n/a n/a
2023-02-09 2022-12-31 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F KURA ONCOLOGY COM Put 10,000 0.00 137 -25.14 n/a n/a n/a
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM Put 10,000 0.00 183 13.66 n/a n/a n/a
2022-05-12 2022-03-31 13F KURA ONCOLOGY COM Put 10,000 96.08 161 126.76 n/a n/a n/a
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM Put 5,100 -74.88 71 -81.32 n/a n/a n/a
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM Put 20,300 -1.93 380 -12.04 n/a n/a n/a
2021-08-10 2021-06-30 13F KURA ONCOLOGY COM Put 20,700 432 n/a n/a n/a
2021-05-12 2021-03-31 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-10 2020-12-31 13F KURA ONCOLOGY COM Put 17,200 562 n/a n/a n/a
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM Put 600 0.00 10 66.67 n/a n/a n/a
2020-05-13 2020-03-31 13F KURA ONCOLOGY COM Put 600 0.00 6 -40.00 n/a n/a n/a
2019-02-05 2018-12-31 13F KURA ONCOLOGY COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F KURA ONCOLOGY COM Put 600 -93.62 11 -93.57 n/a n/a n/a
2018-08-13 2018-06-30 13F KURA ONCOLOGY COM Put 9,400 261.54 171 248.98 n/a n/a n/a
2018-05-16 2018-03-31 13F/A KURA ONCOLOGY COM Put 2,600 2,500.00 49 2,350.00 n/a n/a n/a
2018-05-10 2018-03-31 13F KURA ONCOLOGY COM Put 2,600 49 n/a n/a n/a
2018-02-09 2017-12-31 13F KURA ONCOLOGY COM Put 100 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.